Antiverse - Crunchbase Company Profile & Funding

Q: Where is Antiverse's headquarters?

Antiverse is located in Cardiff, Cardiff, United Kingdom.

Q: Who invested in Antiverse?

Antiverse has 22 investors including Kadmos Capital And Soulmates Ventures.

Q: When was the last funding round for Antiverse?

Antiverse closed its last funding round on obfuscated from a Series A round.

Q: How much funding has Antiverse raised to date?

Antiverse has raised obfuscated.

Overview

Antiverse

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Antiverse

CB Rank

10887

Antiverse is dedicated to engineering the future of drug development to change the course of people's lives.

Founded

obfuscation

Private

Series A

Cardiff, Cardiff, United Kingdom

11-50

antiverse.io

Artificial Intelligence (AI)

Biotechnology

Health Care

Life Science

Machine Learning

Funding Rounds

Series A

OBF

obfuscation

Seed

OBF

obfuscation

Seed

OBF

obfuscation

Key People

Murat Tunaboylu: Co-founder and CEO
Past Role: Antiverse, Co-founder, Bioinformatician
Ben Holland: Co-founder and CTO

Details

Legal Name

Antiverse

Operating Status

Active

Company Type

For Profit

Founders

Ben Holland, Murat Tunaboylu, Rowina Westermeier

About the Company

Antiverse is a new type of antibody discovery company accelerating drug development. Its platform exists at the intersection of structural biology, machine learning, and medicine to enable breakthroughs to happen more quickly and cost-effectively. It is dedicated to engineering the future of drug development to change the course of people's

lives.

Contact Email

info@antiverse.io

Predictions & Insights

Growth Insight

See this Growth Insight

Antiverse is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

Machine Learning Design Engine

A computational platform that designs target-specific antibody libraries by predicting sequences with high binding probability without needing pre-existing data.

State-Of-The-Art Laboratory Facilities

Laboratory infrastructure that prepares unique cell lines expressing millions of target receptors to screen antibody libraries for binders with desired efficacy and affinity.

Research & Development

Antiverse is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Antiverse	8	obfuscated obfuscation	Soulmates Ventures	Series A
obfuscated obfuscation	Series A - Antiverse	8	obfuscated obfuscation	Soulmates Ventures	Series A
obfuscated obfuscation	Series A - Antiverse	8	obfuscated obfuscation	Soulmates Ventures	Series A
obfuscated obfuscation	Series A - Antiverse	8	obfuscated obfuscation	Soulmates Ventures	Series A
obfuscated obfuscation	Series A - Antiverse	8	obfuscated obfuscation	Soulmates Ventures	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Antiverse	8	obfuscated obfuscation	Soulmates Ventures	Series A
obfuscated obfuscation	Series A - Antiverse	8	obfuscated obfuscation	Soulmates Ventures	Series A
obfuscated obfuscation	Series A - Antiverse	8	obfuscated obfuscation	Soulmates Ventures	Series A
obfuscated obfuscation	Series A - Antiverse	8	obfuscated obfuscation	Soulmates Ventures	Series A
obfuscated obfuscation	Series A - Antiverse	8	obfuscated obfuscation	Soulmates Ventures	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Kadmos Capital	—	Series A - Antiverse	John Gebeily
Kadmos Capital	—	Series A - Antiverse	John Gebeily
Kadmos Capital	—	Series A - Antiverse	John Gebeily
Kadmos Capital	—	Series A - Antiverse	John Gebeily
Kadmos Capital	—	Series A - Antiverse	John Gebeily